Industry news that matters to you.  Learn more

Sanguine Brings Smart Technology and Mobile Health Force to the Clinical Trial Space

Sanguine, a leading technology company providing services to the personalized medicine and biomedical research market, recently announced that they will be expanding their services to improve clinical trial efficiency through enhanced patient recruitment, retention and trial procedures. Sanguine, which primarily operated in the pre-clinical space until now, will be fulfilling a big need in later stage clinical development through a combination of their smart technology and adaptable mobile health force.

Enrollment in Pharmatech’s Revolutionary AccessPPM Program Launches

Pharmatech commences enrollment for its AccessPPM program after a two year investment into this game-changing method for matching cancer patients to cancer clinical trials.

Omicia and LabCorp Collaborate to Offer Comprehensive Genomic Analysis Services for Next-Generation Clinical Trials

Omicia, Inc. recently announced that Omicia’s clinical next-generation sequencing (NGS) interpretation software will be used by Laboratory Corporation of America® Holdings (LabCorp®) for its clinical trials sequencing services. LabCorp’s broad menu of testing services, combined with Omicia’s flexible, powerful, and easy-to-use genome analysis platform, will allow the companies to provide a comprehensive suite of expert tools and services for incorporating genomic data into clinical trials. Omicia’s software allows users to quickly and easily annotate genomes, analyze variant data, and generate customized clinical reports for individual patients and research projects across a broad range of disease states and clinical trial designs. Customers can also store, analyze, and manage their clinical trial data within a highly secure environment.

New Versions of JMP Life Sciences Solutions Fuel Discoveries in Clinical Trials, Genomics Research

Risk-based monitoring methods new in JMP® Clinical software from SAS limit costly on-site audits of source data during clinical trials while protecting study participants. JMP Genomics now offers enhanced capabilities for analyzing data related to agriculture, pharmacogenomics, biotechnology and more.

Thomson Reuters Launches New Clinical Trial Intelligence Solution

The Intellectual Property & Science business of Thomson Reuters, the world’s leading provider of intelligent information for businesses and professionals, recently announced the addition of Clinical Trials Intelligence to the Thomson Reuters Cortellis suite, the industry’s most comprehensive information solution for drug discovery and development.